にきび治療薬の世界市場レポート 2025年

にきび治療薬の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.2％で75億1,000万米ドルに成長します。予測期間の成長は、経済成長の加速、ヘルスケア支出の増加、新興国の高い潜在能力、10代人口の増加、座りがちなライフスタイルなどに起因すると考えられます。予測期間における主な動向としては、ナロースペクトル抗生物質への投資、ニキビ治療のための併用療法の開発、大麻オイルからなる大麻製品への投資、新薬開発のためのパートナーシップへの投資、ニキビ治療製品を販売するためのソーシャルメディアの活用などが挙げられます。

個人の可処分所得の増加は、ニキビ治療薬市場の成長を促す重要な要因です。このような可処分所得の増加は、一般的に経済が好調になることで賃金や給与が上昇し、それがヘルスケア支出を押し上げることにつながります。例えば、2023年7月、経済分析局は可処分所得が73億米ドル増加すると報告しています。可処分所得の増加とフェイシャルケア製品への支出の増加というこの動向は今後も続くとみられ、予測期間中の市場をさらに押し上げるものと思われます。

ニキビの有病率の上昇は、ニキビ治療薬市場の今後の成長を促進すると予想されます。ニキビは、皮脂や古い角質が毛穴をふさぐことで生じる皮膚疾患です。ニキビ治療薬は、炎症を抑え、油の分泌を低下させ、毛穴の詰まりを防ぐことで、最終的にニキビができやすい肌の見た目を改善します。ニキビは広く蔓延している問題で、世界的に見ても90％近くの人が罹患しています。例えば、Click2Pharmacyが2022年5月に発表したレポートによると、英国では成人の34％以上がニキビを経験したことがあり、現在11.5％が発症しています。この数字は若年層では24％に増加します。その結果、ニキビの発生率の増加がニキビ治療薬市場の拡大に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界にきび治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のにきび治療薬市場：成長率分析
• 世界のにきび治療薬市場の実績：規模と成長, 2019-2024
• 世界のにきび治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界にきび治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のにきび治療薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 炎症性のにきび治療薬
• 非炎症性にきび治療薬
• 世界のにきび治療薬市場治療クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• レチノイド
• 抗生物質
• サリチル酸
• 過酸化ベンゾイル
• その他の治療法
• 世界のにきび治療薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 薬局とドラッグストア
• その他のエンドユーザー
• 世界のにきび治療薬市場炎症性ニキビ治療薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質（外用および経口）
• 抗炎症薬
• コルチコステロイド
• 併用療法
• 世界のにきび治療薬市場非炎症性ニキビ治療薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• レチノイド（外用および経口）
• 過酸化ベンゾイル
• サリチル酸
• アルファヒドロキシ酸（AHA）
• 市販薬（OTC）による治療

第7章 地域別・国別分析

• 世界のにきび治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のにきび治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• にきび治療薬市場：競合情勢
• にきび治療薬市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Almirall SA Overview, Products and Services, Strategy and Financial Analysis
  • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Reckitt Benckiser Group
• Mayne Pharma Group Limited
• Allergan Plc.
• Cipher Pharmaceuticals
• Sol Gel Advanced Topical Therapy
• Pfizer Inc.
• Novartis AG
• Merck & Co. Inc.
• Amgen Inc.
• Eli Lilly and Company
• Daiichi Sankyo Company Limited
• Sinopharm Group Co. Ltd
• Mylan N.V.
• F. Hoffmann-La Roche Ltd
• Bayer AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• にきび治療薬市場2029：新たな機会を提供する国
• にきび治療薬市場2029：新たな機会を提供するセグメント
• にきび治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Acne medications encompass pharmaceutical solutions designed to address issues related to acne scarring, blackheads, whiteheads, and more severe forms of the condition. These drugs operate by either targeting bacterial infections or reducing edema and oil production. Typically, a timeframe of four to eight weeks is required before prescription acne medications demonstrate efficacy. Complete resolution of acne may extend over several months or even years.

The primary categories of acne drugs include inflammatory and non-inflammatory variants. Inflammatory acne drugs are employed for the treatment of mild to moderate inflammatory acne. Key therapeutic classes comprise retinoids, antibiotics, salicylic acid, and benzoyl peroxide. These medications find application across various end-user segments, including hospitals, clinics, pharmacies, drug stores, and ambulatory surgical centers.

The acne drugs market research report is one of a series of new reports from The Business Research Company that provides acne drugs market statistics, including acne drugs industry global market size, regional shares, competitors with an acne drugs market share, detailed acne drugs market segments, market trends and opportunities, and any further data you may need to thrive in the acne drugs industry. This acne drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acne drugs market size has grown steadily in recent years. It will grow from $6.09 billion in 2024 to $6.36 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to an increase in acne prevalence, rising population, strong economic growth increase in pharmaceutical expenditure, rise in disposable income, and increased healthcare expenditure.

The acne drugs market size is expected to see steady growth in the next few years. It will grow to $7.51 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to faster economic growth, rise in healthcare expenditure, high potential of emerging economies, increasing teenage population and sedentary lifestyles. Major trends in the forecast period include investing in narrow-spectrum antibiotics, developing combination therapies for acne treatment, investing in cannabis products consisting of cannabis oil, investing in partnerships to develop new drugs, and using social media to market acne treatment products.

A rise in disposable income among individuals is a significant factor driving growth in the acne drug market. This increase in disposable income typically results from a stronger economy, leading to higher wages and salaries, which in turn boosts healthcare spending. For example, in July 2023, the Bureau of Economic Analysis reported a $7.3 billion increase in disposable personal income. This trend of rising disposable income and heightened spending on facial care products is expected to persist, further propelling the market during the forecast period.

The rising prevalence of acne is anticipated to drive growth in the acne drug market moving forward. Acne is a skin condition that arises when oil and dead skin cells block pores. Acne medications work by reducing inflammation, lowering oil production, and preventing clogged pores, ultimately enhancing the appearance of skin prone to acne. Acne is a widespread issue, affecting nearly 90% of individuals globally. For example, a report published by Click2Pharmacy in May 2022 indicated that over 34% of adults in the UK have experienced acne at some point, with 11.5% currently affected. This number increases to 24% among young adults. Consequently, the growing incidence of acne is fueling the expansion of the acne drug market.

The latest trend shaping the acne drug market is the adoption of combination therapy, involving the simultaneous use of two drugs with distinct mechanisms of action. Such combinations exhibit enhanced efficacy and improved adherence compared to monotherapy, which involves using a single drug in isolation. This approach combines a topical retinoid drug, effective in unclogging pores, with an antimicrobial drug utilized for treating infections in acne management. Examples of combination therapy include products such as Epiduo, Acanya, Ziana, and Benzamycin, manufactured by Galderma, Allergan, Medicis, and Atrix, respectively.

Leading companies operating in the acne drug market are actively engaged in developing advanced receptor inhibitor drugs and broadening their research into treatment advancements to gain a competitive edge in the burgeoning healthcare sector. Advanced receptor inhibitor drugs function by blocking the activity of specific receptors within the body. For instance, in September 2023, Sun Pharmaceutical Industries Ltd., an India-based biopharmaceutical company, introduced (PR)WINLEVI (clascoterone cream 1% w/w). WINLEVI is formulated to mitigate the effects of acne hormones on the skin by disrupting the androgen cascade, departing from the topical approach in acne treatment that targets follicular hyperkeratinization, inflammation reduction, or antibacterial properties. While the precise mechanism of action of WINLEVI remains under study, it aims to suppress androgen receptor activities within sebaceous gland cells, thereby reducing sebum (oil) production and inflammatory cytokines associated with acne.

In May 2024, Lindus Health, a UK-based company known for conducting decentralized clinical trials with an emphasis on speed and efficiency across various therapeutic areas, partnered with Acinonyx Bio to initiate a cosmetic clinical trial for Acinonyx Bio's topical cream, ACX, designed to treat inflammatory acne. This trial will target patients with moderate to severe inflammatory acne and will utilize a decentralized approach, allowing participants to engage from their everyday environments. Acinonyx Bio, also based in the UK, is dedicated to developing innovative dermatological treatments.

Major companies operating in the acne drugs market include Johnson & Johnson, Galderma S.A., Almirall SA, Bausch Health Companies Inc., GlaxoSmithKline, Reckitt Benckiser Group, Mayne Pharma Group Limited, Allergan Plc., Cipher Pharmaceuticals, Sol Gel Advanced Topical Therapy, Pfizer Inc., Novartis AG, Merck & Co. Inc., Amgen Inc., Eli Lilly and Company, Daiichi Sankyo Company Limited, Sinopharm Group Co. Ltd, Mylan N.V., F. Hoffmann-La Roche Ltd, Bayer AG, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries Ltd., Allergan, Cipla Inc., Zydus Cadila, Otsuka Pharmaceutical Co. Ltd, Shanghai Pharmaceuticals Holding Co. Ltd, Jiangsu Hengrui Medicine, Guangzhou Baiyunshan Pharmaceutical, China Meheco Co Ltd, Huadong Medicine Co. Ltd., Ranbaxy Laboratories, Stiefel Laboratories, BIOCAD, Zentiva (Sanofi), Gedeon Richter Plc, Polpharma SA Pharmaceutical Works, Egis Group, Dermira Inc., Estee Lauder Inc., Nimue Skincare International.

North America was the largest region in the acne drugs market in 2024. Middle East is expected to be the largest growing region in the global acne drugs market during the forecast period. The regions covered in the acne drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the acne drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The acne drugs market consists of sales of retinoids, antibiotics, and diapsone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acne Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acne drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acne drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acne drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs
• 2) By Therapeutic Class: Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics
• 3) By End User: Hospitals And Clinics, Pharmacies And Drug Stores, Other End Users
• Subsegments:
• 1) By Inflammatory Acne Drugs: Antibiotics (Topical And Oral); Anti-inflammatory Drugs; Corticosteroids; Combination Therapies
• 2) By Non-Inflammatory Acne Drugs: Retinoids (Topical And Oral); Benzoyl Peroxide; Salicylic Acid; Alpha Hydroxy Acids (AHAs); Over-The-Counter (OTC) Treatments
• Companies Mentioned: Johnson & Johnson; Galderma S.A.; Almirall SA; Bausch Health Companies Inc.; GlaxoSmithKline
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acne Drugs Market Characteristics

3. Acne Drugs Market Trends And Strategies

4. Acne Drugs Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Acne Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acne Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acne Drugs Market Growth Rate Analysis
• 5.4. Global Acne Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acne Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acne Drugs Total Addressable Market (TAM)

6. Acne Drugs Market Segmentation

• 6.1. Global Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Acne Drugs
• Non-Inflammatory Acne Drugs
• 6.2. Global Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retinoids
• Antibiotics
• Salicylic Acid
• Benzoyl Peroxide
• Other Therapeutics
• 6.3. Global Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Pharmacies And Drug Stores
• Other End Users
• 6.4. Global Acne Drugs Market, Sub-Segmentation Of Inflammatory Acne Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics (Topical and Oral)
• Anti-inflammatory Drugs
• Corticosteroids
• Combination Therapies
• 6.5. Global Acne Drugs Market, Sub-Segmentation Of Non-Inflammatory Acne Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retinoids (Topical and Oral)
• Benzoyl Peroxide
• Salicylic Acid
• Alpha Hydroxy Acids (AHAs)
• Over-The-Counter (OTC) Treatments

7. Acne Drugs Market Regional And Country Analysis

• 7.1. Global Acne Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acne Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acne Drugs Market

• 8.1. Asia-Pacific Acne Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acne Drugs Market

• 9.1. China Acne Drugs Market Overview
• 9.2. China Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acne Drugs Market

• 10.1. India Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acne Drugs Market

• 11.1. Japan Acne Drugs Market Overview
• 11.2. Japan Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acne Drugs Market

• 12.1. Australia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acne Drugs Market

• 13.1. Indonesia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acne Drugs Market

• 14.1. South Korea Acne Drugs Market Overview
• 14.2. South Korea Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acne Drugs Market

• 15.1. Western Europe Acne Drugs Market Overview
• 15.2. Western Europe Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acne Drugs Market

• 16.1. UK Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acne Drugs Market

• 17.1. Germany Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acne Drugs Market

• 18.1. France Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acne Drugs Market

• 19.1. Italy Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acne Drugs Market

• 20.1. Spain Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acne Drugs Market

• 21.1. Eastern Europe Acne Drugs Market Overview
• 21.2. Eastern Europe Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acne Drugs Market

• 22.1. Russia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acne Drugs Market

• 23.1. North America Acne Drugs Market Overview
• 23.2. North America Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acne Drugs Market

• 24.1. USA Acne Drugs Market Overview
• 24.2. USA Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acne Drugs Market

• 25.1. Canada Acne Drugs Market Overview
• 25.2. Canada Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acne Drugs Market

• 26.1. South America Acne Drugs Market Overview
• 26.2. South America Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acne Drugs Market

• 27.1. Brazil Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acne Drugs Market

• 28.1. Middle East Acne Drugs Market Overview
• 28.2. Middle East Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acne Drugs Market

• 29.1. Africa Acne Drugs Market Overview
• 29.2. Africa Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acne Drugs Market Competitive Landscape And Company Profiles

• 30.1. Acne Drugs Market Competitive Landscape
• 30.2. Acne Drugs Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Almirall SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline Overview, Products and Services, Strategy and Financial Analysis

31. Acne Drugs Market Other Major And Innovative Companies

• 31.1. Reckitt Benckiser Group
• 31.2. Mayne Pharma Group Limited
• 31.3. Allergan Plc.
• 31.4. Cipher Pharmaceuticals
• 31.5. Sol Gel Advanced Topical Therapy
• 31.6. Pfizer Inc.
• 31.7. Novartis AG
• 31.8. Merck & Co. Inc.
• 31.9. Amgen Inc.
• 31.10. Eli Lilly and Company
• 31.11. Daiichi Sankyo Company Limited
• 31.12. Sinopharm Group Co. Ltd
• 31.13. Mylan N.V.
• 31.14. F. Hoffmann-La Roche Ltd
• 31.15. Bayer AG

32. Global Acne Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acne Drugs Market

34. Recent Developments In The Acne Drugs Market

35. Acne Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Acne Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acne Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acne Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer